Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Glioblastoma 9Recurrence 1Oligodendroglioma 1Neoplasms 1Neoplasm Recurrence, Local 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Glioma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 30blinatumomab 19Vincristine 17Methotrexate 14Specimen Handling 13Prednisone 13Dexamethasone 13fludarabine 12Cytarabine 12Biopsy 11Mercaptopurine 9Doxorubicin 9Asparaginase 9venetoclax 8merphos 8Rituximab 8Inotuzumab Ozogamicin 8prednylidene 7deltacortene 7azathiopurine 7Spinal Puncture 7N,N-dicyclohexyl-isoborneol-10-sulfonamide 7Magnetic Resonance Spectroscopy 7Daunorubicin 7pegaspargase 6dexamethasone acetate 6dexamethasone 21-phosphate 6auricularum 6Etoposide 6Calcium Dobesilate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Burkitt Lymphoma × Lomustine × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡